News & Updates

Introducing MYTOLAC® MYTOLAC® is the first generic containing lanreotide. ADVANZ PHARMA Canada is committed to supporting your patients throughout their MYTOLAC® treatment journey with our NAVIGATE® Patient Support Program.

Dear Healthcare Professional,

You are invited to participate in a global survey on thromboprophylaxis practices for patients with cancer receiving ambulatory systemic therapies.

The first virtual coffee with the CAPhO Board of Directors took place on Tuesday, April 29 at 11am PD

Are you looking to strengthen your knowledge in hematology? The University of Toronto’s Leslie Dan Faculty of Pharmacy invites you to Blood Cancer Day, a conference designed to provide pharmacists with a comprehensive introduction to hematology.

The Canadian Association of Pharmacy in Oncology (CAPhO), is a proud Canadian organization that represents oncology pharmacy in Canada, where values such as inclusivity, equitable access to healthcare, and evidence-based medicine matter.

ISOPP CAPhO Symposium 2025 is less than 4 weeks away! Join us for leading edge education to advance your oncology pharmacy knowledge in the vibrant heart of downtown Victoria, on Vancouver Island in British Columbia, Canada. Read more for the top reasons to attend!

This survey assesses CAR T cell therapy use in DLBCL, focusing on educational gaps in awareness, barriers to use, and adverse event management. Your confidential input will optimize clinical practice and improve outcomes.

Save the date, Wednesday, February 26, 2025 at 13:00 PST, for the first of several collaborative webinars between COSA, CAPhO, BOPA and ISOPP.

Is your organization looking to hire oncology pharmacy professionals?

Apply to be mentored, by Sunday, February 16, 2025, via CAPhO’s Research Mentorship Network application site.